Solasonine Anti-Cancer Mechanisms and SRC Validation in Hepatocellular Carcinoma

A research paper by Zheng Liu analyzes the anti-cancer mechanisms of solasonine across multiple cancer types. The study employs bibliometric analysis, network pharmacology, and experimental validation in hepatocellular carcinoma cell lines. The PDF file was last updated on April 27, 2026.

Use Cases

• Identify core drug targets for natural compounds based on network pharmacology results
• Validate predicted hub targets like SRC using experimental assays described in the paper
• Explore pan-cancer therapeutic potential based on bibliometric research landscape mapping

Strengths

• The study integrates computational prediction with experimental validation in HCC cell lines
• Identifies eight specific core targets, including SRC, EGFR, and AKT1

Limitations

• The dataset is a single PDF file; column-level data structure is unknown
• Row count is unknown, which may limit suitability assessment
• The description is detailed but lacks explicit data tables or sample records

Provenance

Source

Zheng Liu

Collection Method

Bibliometric analysis, network pharmacology, and experimental assays (qRT-PCR, Western blotting, CCK-8)

Freshness

Last updated 2026-04-27 09:27:20